Clindamycin Phosphate & Benzoyl Peroxide Gel 1.2%/3.75%
Clindamycin Phosphate & Benzoyl Peroxide Gel 1.2%/3.75%
Product Description
A prescription-strength topical gel combining two clinically proven acne-fighters β Clindamycin Phosphate 1.2% (a lincosamide antibiotic) and Benzoyl Peroxide 3.75% (an antibacterial and keratolytic agent) β in a single once-daily application. Manufactured by Taro Pharmaceuticals, this smooth white-to-off-white aqueous gel targets inflammatory acne vulgaris at its root: killing acne-causing bacteria, reducing inflammation, and preventing antibiotic resistance simultaneously. FDA-approved for patients 12 years and older.
β¨ Texture & Feel
Dual Antibacterial Action
Clindamycin inhibits bacterial protein synthesis while benzoyl peroxide generates free radicals that kill P. acnes bacteria. Together they work via two separate mechanisms, reducing the chance of resistance developing.
Resistance Prevention
Benzoyl peroxide prevents the antibiotic resistance that can occur with clindamycin monotherapy. This combination is the gold-standard approach recommended by dermatology guidelines.
Once-Daily Convenience
Apply just a pea-sized amount to the entire face once daily. The 3.75% BPO concentration is lower than the traditional 5%, offering effective results with improved tolerability and less dryness.
Clinically Proven Efficacy
In Phase III clinical trials, this formulation produced median reductions of 68.4% in inflammatory lesions and 57.9% in non-inflammatory lesions from baseline after 12 weeks of once-daily use.
Silicone-Smoothing Base
Dimethicone in the formula provides a silky, smooth application and helps protect the skin barrier, reducing some of the irritation associated with benzoyl peroxide treatments.
Optimized BPO Concentration
The 3.75% benzoyl peroxide is specifically formulated to balance efficacy and tolerability. Research shows it is better tolerated than 5% BPO combinations while maintaining comparable clinical outcomes.
π‘οΈ Safety & Compatibility
Use during pregnancy only when clearly needed β consult your physician. The FDA formerly classified this as Pregnancy Category C (animal studies showed adverse fetal effects; no adequate human studies). Topical absorption is low, but caution is advised. Always discuss with your OB-GYN before use.
Unknown if this form passes into breast milk. Oral clindamycin has been detected in breast milk in small amounts. If applying to the chest area while breastfeeding, take care to avoid contact with infant. Consult your doctor before breastfeeding while using this medication.
This formula does not contain fermented ingredients, fatty acid esters, polysorbates, or oils known to feed Malassezia fungus. The formula is considered safe for fungal acne-prone skin. Benzoyl peroxide may also have mild antifungal properties.
Very low comedogenic risk. The gel base uses water-soluble and silicone-based ingredients. Dimethicone has a comedogenic rating of 1, and no pore-clogging oils are present. Suitable for acne-prone and congestion-prone skin.
Benzoyl peroxide CAN bleach hair, colored fabrics, pillowcases, and clothing. Use white or old towels and pillowcases when using this product. Avoid contact with colored fabric items until the gel has fully absorbed.
As an antibiotic-containing product, use only as directed by your prescriber. Do not use longer than prescribed (typically up to 12 weeks evaluated in clinical trials). The BPO component helps mitigate resistance risk, but antibiotic stewardship is important.
For external topical use only. Avoid contact with eyes, mouth, mucous membranes, or areas of broken skin. If contact with eyes occurs, rinse thoroughly with water. Keep out of reach of children.
Do not use if you have a history of hypersensitivity to clindamycin, lincomycin, or benzoyl peroxide. Also contraindicated in patients with a history of regional enteritis, ulcerative colitis, or antibiotic-associated colitis (pseudomembranous colitis).
π¬ Ingredient Breakdown
π Clindamycin Phosphate 1.2% Proven
A water-soluble ester of the lincosamide antibiotic clindamycin. As the primary active ingredient, it works by binding to the 50S ribosomal subunit of bacteria, inhibiting protein synthesis and stopping the growth and spread of Cutibacterium acnes (formerly P. acnes) β the primary bacteria responsible for inflammatory acne. Each gram of gel contains 12 mg of clindamycin phosphate, equivalent to 10 mg (1%) of the active clindamycin base.
- Mechanism: Bacteriostatic β inhibits bacterial protein synthesis at the 50S ribosome
- Indication: FDA-approved for topical treatment of inflammatory acne vulgaris
- Absorption: Minimal systemic absorption via topical use; reduces antibiotic resistance risk vs. oral use
- Efficacy: Significantly more effective in combination with BPO than as monotherapy; BPO prevents clindamycin-resistant P. acnes strains
π§ͺ Benzoyl Peroxide 3.75% Proven
An oxidizing agent with potent bactericidal and mild keratolytic (exfoliating) properties. Benzoyl peroxide generates free radical oxygen species upon contact with skin, killing acne-causing bacteria through oxidative stress β a mechanism that bacteria cannot develop resistance to. The 3.75% concentration in this formula is strategically lower than the commonly used 5%, offering comparable effectiveness with significantly improved tolerability and reduced dryness/peeling.
- Mechanism: Bactericidal β oxidative destruction of bacterial cell walls; bacteria cannot develop resistance
- Dual Role: Antibacterial + mild keratolytic (helps unclog pores by promoting skin cell turnover)
- Resistance Prevention: Prevents clindamycin-resistant C. acnes strains from developing
- Clinical Data: Phase III trial: 68.4% median reduction in inflammatory lesions at 12 weeks vs. vehicle
𧬠Dimethicone Inactive Proven
A synthetic silicone polymer derived from natural quartz. In this gel, dimethicone serves as an emollient and skin-conditioning agent, providing a smooth application texture and forming a breathable barrier on the skin surface. It helps counteract some of the drying effects of benzoyl peroxide, improving overall tolerability and skin feel without contributing to pore clogging (comedogenic rating: 1).
- Function: Emollient, skin protectant, texture enhancer β creates silky slip
- Barrier Support: Forms a non-occlusive film that reduces transepidermal water loss (TEWL)
- Tolerability: Helps offset BPO-induced dryness and irritation
πΏ Glycerin Inactive Proven
A naturally derived humectant that draws water from the environment and deeper skin layers into the stratum corneum, maintaining optimal skin hydration. Its inclusion in this formula is important because both clindamycin and benzoyl peroxide formulations can be drying β glycerin serves as a counterbalance to support skin barrier health during treatment.
- Function: Humectant β attracts and retains moisture in the epidermis
- Comedogenic Rating: 0 β non-comedogenic
- Safety: Well-tolerated by all skin types; no known allergenicity
π§Ό Disodium Lauryl Sulfosuccinate Inactive Promising
A mild anionic surfactant and emulsifier used to help disperse the active ingredients uniformly throughout the gel base. Unlike harsher SLS (sodium lauryl sulfate), disodium lauryl sulfosuccinate is considered gentler on skin and is less likely to cause irritation, making it a more skin-compatible choice in a prescription formulation where tolerability is critical.
- Function: Surfactant/emulsifier β stabilizes gel formulation; aids even ingredient distribution
- Gentleness: Considered a mild alternative to SLS; lower irritation potential
π Disodium EDTA Inactive Proven
A chelating agent (ethylenediaminetetraacetic acid disodium salt) that binds to metal ions in the formula, preventing them from interacting with other ingredients and destabilizing the formulation. It also has a mild preservative-enhancing effect and can slightly improve the penetration of other active ingredients by disrupting the lipid layer of bacterial cell membranes.
- Function: Chelating agent β stabilizes formula, extends shelf life, enhances preservative efficacy
- Synergistic Effect: May enhance the efficacy of antibacterial ingredients by weakening bacterial cell membranes
βοΈ Poloxamer 407 Inactive Proven
A non-ionic block copolymer surfactant used as a gel-forming agent and emulsifier. Poloxamer 407 is known for its thermoreversible gelation properties β it helps create the smooth, consistent gel texture of this product and ensures stable dispersion of both water-soluble (clindamycin) and oil-compatible (BPO) components throughout the formula.
- Function: Gelling agent, solubilizer, emulsifier β gives the product its gel consistency
- Biocompatibility: Widely used in pharmaceutical and cosmetic preparations; considered biocompatible and non-irritating
π‘οΈ Methylparaben Inactive Proven
A commonly used preservative from the paraben family that prevents microbial contamination (bacteria and mold) in the formulation, extending shelf life and ensuring product safety. Methylparaben is considered one of the safest parabens, with extensive history of use in pharmaceutical products. At the low concentrations used in topical products, it is well-tolerated by most users.
- Function: Preservative β prevents bacterial and fungal contamination
- Concentration: Used at very low levels (typically 0.1β0.3%) in topical formulations
- Safety Status: EU CosIng and FDA-permitted preservative at approved concentrations
βοΈ Sodium Hydroxide Inactive Proven
A pH adjuster (alkali) used in tiny amounts to bring the formulation's pH to the optimal range for skin compatibility and ingredient stability. Maintaining the correct pH is critical in this combination product: it ensures both clindamycin phosphate remains stable and bioavailable, and that the gel remains comfortable and non-irritating on skin (target pH close to skin's natural ~4.5β5.5).
- Function: pH adjuster β neutralizes acid, optimizes formulation pH for stability and tolerability
- Safety: Used at trace amounts; fully neutralized in the final formula; safe as a pH balancer
π Silicon (Silica) Inactive Proven
Silica or silicon dioxide functions as an absorbent and texturizing agent in the gel base. It helps create a smooth, non-sticky skin feel after application and may assist in absorbing excess sebum on the skin surface, contributing to the product's matte finish. It also helps ensure uniform dispersion of active ingredients throughout the gel matrix.
- Function: Absorbent, texturizing agent β improves skin feel, reduces tackiness
- Comedogenic Rating: 0 β fully non-comedogenic
10 ingredients total
Active Ingredients: Clindamycin Phosphate 1.2% (equivalent to 1% Clindamycin base), Benzoyl Peroxide 3.75%
Inactive Ingredients: Dimethicone, Disodium Lauryl Sulfosuccinate, Disodium EDTA, Glycerin, Silicon, Methylparaben, Poloxamer 407, Water (Purified Water / Aqua), Sodium Hydroxide
π Where It Fits in Your Routine
Apply after cleansing and patting skin dry. Allow the gel to absorb before applying moisturizer. Use once daily β most patients apply in the evening to minimize sun interaction with BPO. Always follow with broad-spectrum SPF 30+ sunscreen in the morning.
π How to Use
Cleanse Gently
Wash your face gently with a mild, non-medicated cleanser. Rinse thoroughly with warm water and pat the skin completely dry. Avoid harsh scrubbing or exfoliating cleansers on the same application day.
Dispense a Pea-Sized Amount
Pump a pea-sized amount of gel onto a clean fingertip. This small amount is sufficient to cover the entire face. Using more product does not increase efficacy and will increase the risk of irritation and dryness.
Apply Evenly to Face
Gently smooth the gel across the entire face, avoiding the eyes, mouth, nostrils, and any areas of broken skin. The gel is intended as a full-face treatment, not a spot treatment. Use light, sweeping motions to apply evenly.
Allow to Absorb
Let the gel absorb fully before applying other skincare products. This typically takes 30β60 seconds. Do not rinse off. The medication works on the skin throughout the day or night.
Apply Moisturizer
Follow with a non-comedogenic, fragrance-free moisturizer to counteract any potential dryness from BPO. This step is especially important during the first 2β4 weeks of treatment as skin adjusts.
Apply Sunscreen in the Morning (AM Use)
If applying in the morning, always finish with a broad-spectrum SPF 30+ sunscreen. BPO can increase photosensitivity. If applying at night, skip this step. Whichever time you choose, stay consistent β apply at the same time each day.
π€ Who Is It For?
β Perfect for you if:
- You have inflammatory acne vulgaris (papules, pustules, nodules)
- You are 12 years of age or older
- Your dermatologist has prescribed this medication
- You want a convenient once-daily acne treatment
- You have moderate-to-severe inflammatory acne that hasn't responded to OTC treatments
- You have oily or combination skin prone to breakouts
- You want to target acne bacteria while preventing antibiotic resistance
β Consider alternatives if:
- You are pregnant β consult your physician before use
- You have a history of colitis, Crohn's disease, or antibiotic-associated colitis
- You are allergic to clindamycin, lincomycin, or benzoyl peroxide
- You primarily have non-inflammatory acne (blackheads/whiteheads only) β a retinoid may be more appropriate
- You have very dry, eczema-prone, or rosacea skin β may cause excessive irritation
- You frequently use colored fabrics/pillow covers and cannot switch to white ones
- You are under 12 years of age β safety and effectiveness not established
π― Skin Type Compatibility
Ideal match. The lightweight aqueous gel absorbs quickly without adding greasiness. BPO helps reduce excess sebum production and keeps pores clear. The matte finish is particularly flattering on oily skin.
Works very well. Gel texture controls oil in the T-zone while glycerin and dimethicone maintain hydration in drier areas. Apply moisturizer to drier zones if needed.
This product is specifically formulated for inflammatory acne. The antibiotic + antibacterial dual mechanism is the gold standard for acne-prone skin. Non-comedogenic formula won't clog pores.
Suitable with appropriate moisturizer follow-up. Normal skin tolerates BPO reasonably well. Use a hydrating moisturizer daily to maintain balance throughout the course of treatment.
Use with caution. BPO can worsen dryness and flaking. A rich non-comedogenic moisturizer is essential. Start with every-other-day use if skin is significantly dry. Consult your dermatologist for a complementary hydrating protocol.
Proceed carefully. The 3.75% BPO is gentler than 5% formulations, and the fragrance-free formula minimizes reactivity. However, initial redness, burning, or stinging may occur. Start slowly and always follow with a barrier-repair moisturizer.
π Results Timeline
Initial Adjustment Period
Some users may experience an initial purging phase where new breakouts appear as cell turnover accelerates. Mild dryness, redness, and peeling may occur as skin adjusts to benzoyl peroxide. This is normal and typically subsides. Begin using a gentle non-comedogenic moisturizer daily to support skin barrier.
~32% notice early improvements in acne by Week 2 in adolescent patients (clinical trial data)Visible Reduction in Redness and Pimples
Most patients begin to see a noticeable reduction in inflammatory lesions β red, swollen papules and pustules start decreasing in frequency and severity. Skin irritation from BPO usually settles by this point. Existing acne lesions begin to heal faster and new breakouts become less frequent.
~50%+ report visible improvement in acne lesion count within the first monthSignificant Acne Clearance
Continued improvement in both inflammatory and non-inflammatory lesions. Skin texture begins to smooth, post-acne redness (post-inflammatory erythema) starts fading. Treatment success becomes clearly measurable. Cystic lesions, if present, show marked reduction in size and frequency.
~52.7% of adult female patients achieve treatment success by this stageMaximum Clinical Benefit
The full 12-week course delivers peak efficacy results. Clinical studies show a median 68.4% reduction in inflammatory lesions and 57.9% reduction in non-inflammatory lesions from baseline. Over half of severe acne patients (55.1%) achieve at least a 2-grade global improvement. Consistent once-daily use through the full course is critical for best outcomes.
68.4% median reduction in inflammatory lesions vs. vehicle (Phase III clinical trial, p<0.001)β Ratings by Platform
βοΈ Pros & Cons
β Praised
- FDA-approved, clinically proven efficacy for inflammatory acne
- Dual mechanism β antibiotic + antibacterial β reduces resistance risk
- Once-daily application β convenient and easy to maintain
- 3.75% BPO is gentler than 5% alternatives with comparable results
- Fragrance-free, non-comedogenic formula
- Works on hormonal, cystic, and inflammatory acne types
- Clinically shown to work by Week 2 in some patients
- Smooth gel texture absorbs quickly without residue
- Available in easy-to-use pump format
- Fungal acne safe β no Malassezia-feeding ingredients
β Criticized
- Requires a prescription β not available over-the-counter
- Can be expensive without insurance or prescription coverage
- BPO bleaches hair, colored fabrics, and pillowcases
- May cause initial dryness, redness, peeling, or burning sensation
- Initial purging phase possible in weeks 1β2
- Not evaluated for use beyond 12 weeks
- Not safe for those with colitis history
- Contains methylparaben (concern for paraben-sensitive users)
- Must be stored correctly (pharmacy: refrigerated; patient: room temp, upright)
- Discarded 10β12 weeks after dispensing
π° Budget-Friendly Alternatives (Dupes)
Nearly identical formula with slightly lower BPO concentration (2.5% vs. 3.75%). Same clindamycin 1.2% active. Apply once daily. Generic versions widely available. Slightly less BPO means potentially less drying but may be marginally less effective against non-inflammatory lesions.
Available over the counter without a prescription. Swaps the antibiotic clindamycin for adapalene (a retinoid), targeting clogged pores as well as bacteria. Equally effective for mild-to-moderate acne per AAFP guidelines, but works differently β more suitable when comedones (blackheads/whiteheads) are present alongside inflammatory lesions. Lower BPO and no antibiotic means a different efficacy profile.
The original combination antibiotic + BPO gel (applied twice daily). Uses slightly lower clindamycin (1% vs. 1.2%) but higher BPO (5% vs. 3.75%). More widely generic and potentially cheaper, but the higher BPO and twice-daily dosing means greater drying potential. Widely used and well-studied over decades.
π Comparison with Competitors
Taro Clindamycin Phosphate & BPO Gel 1.2%/3.75% (This Product)
Rx RequiredEpiduo Forte (Adapalene 0.3% / BPO 2.5%)
Rx RequiredVeltin / Ziana Gel (Clindamycin 1.2% / Tretinoin 0.025%)
Rx RequiredDifferin Gel (Adapalene 0.1%) β OTC
OTC ~$12β15π¦ Storage & Shelf Life
Dispense with a 10-week expiration date per FDA labeling. Discard any unused product after 10β12 weeks as dispensed by the pharmacy. The short expiry ensures potency and sterility of the active ingredients, particularly BPO which can degrade over time.
PHARMACY: Store refrigerated at 2Β°C to 8Β°C (36Β°F to 46Β°F) prior to dispensing. PATIENT: After dispensing, store at room temperature 20Β°C to 25Β°C (68Β°F to 77Β°F). Protect from freezing. Do not store in the bathroom (humidity and heat degrade the product). Keep container tightly closed and store pump upright.
50g airless pump dispenser. The pump format ensures hygiene by limiting air exposure to the formula, helps prevent oxidative degradation of BPO, and allows precise dispensing of a pea-sized amount. White to off-white opaque smooth gel.
The 50g pump is technically under 100ml/3.4oz for TSA carry-on limits. However, as a prescription medication, always carry with the original pharmacy label and prescription documentation when traveling, especially internationally. Keep away from extreme heat (e.g., car gloveboxes in summer).
β Frequently Asked Questions
This product should be used during pregnancy only when clearly needed and under physician guidance. The FDA formerly classified it as Pregnancy Category C, meaning animal studies showed potential adverse fetal effects and there are no adequate human studies. While topical absorption is limited, both clindamycin and benzoyl peroxide carry precautionary notes. For breastfeeding: it is unknown whether topical application results in levels in breast milk. Oral clindamycin is known to appear in breast milk in small amounts. If you are pregnant or breastfeeding, consult your OB-GYN or dermatologist before use. Many dermatologists will consider topical clindamycin acceptable during pregnancy but may recommend avoiding BPO β your physician will make the risk-benefit assessment for your specific situation.
Yes β this formula is considered fungal acne (Malassezia folliculitis) safe. The ingredient list does not contain fermented ingredients, polysorbates, esters of fatty acids, or problematic plant oils that are known to feed Malassezia yeast. The base uses water, silicone (dimethicone), glycerin, and synthetic surfactants rather than lipid-rich ingredients. Additionally, benzoyl peroxide has demonstrated mild antifungal properties in some studies, which may provide an incidental benefit. If you are simultaneously managing fungal acne alongside bacterial acne, this gel is a compatible treatment to use as part of your regimen.
Use with caution and generally avoid layering on the same application. Combining this prescription gel with other active ingredients increases the risk of irritation, dryness, and compromised skin barrier. Specific guidance: (1) Retinoids (retinol, tretinoin, adapalene): Avoid using in the same application session β separate to AM vs. PM use or alternate nights. Your dermatologist may prescribe a retinoid alongside this product; follow their protocol. (2) Vitamin C (L-ascorbic acid): Can be used on separate occasions; oxidizing agents like BPO may degrade vitamin C, so separate by at least 30 minutes or use at different times. (3) AHA/BHA (glycolic acid, salicylic acid, lactic acid): Avoid combining in the same routine session β compounding chemical exfoliants with BPO significantly increases irritation risk. (4) Erythromycin: Do not use topical or oral erythromycin concurrently β antagonistic effect reduces clindamycin's efficacy. Always follow your prescribing dermatologist's guidance for combination therapies.
This gel is best suited for oily, combination, and acne-prone skin types dealing with inflammatory acne (papules, pustules, nodules, cysts). The lightweight aqueous gel formula absorbs quickly without adding greasiness, and BPO helps control excess sebum. It works well for those who have tried over-the-counter acne treatments without success and need prescription-strength intervention. It is moderately suitable for normal skin with proper moisturizer follow-up. Those with dry or highly sensitive skin should use with extra caution, starting gradually and ensuring robust moisturization, as BPO can be drying and potentially irritating.
Results vary by individual, but clinical data provides a useful timeline. Some improvement may be visible as early as Week 2, particularly in adolescent patients. Most patients see meaningful reductions in inflammatory lesions by Weeks 3β4. Significant improvement β including reduced breakout frequency and healing of existing lesions β is typically observed at Weeks 5β8. Maximum clinical benefit occurs at the end of the full 12-week course, with clinical trials showing a median 68.4% reduction in inflammatory lesions. It is important not to discontinue the medication prematurely during a purging or adjustment phase in the first 1β2 weeks. Patience and consistent daily use are key to achieving optimal outcomes.
Apply this gel as the treatment step after cleansing and before moisturizing. The recommended routine order is: (1) Gentle cleanser β rinse and pat dry, (2) Optional toner if prescribed or used, (3) Apply a pea-sized amount of this gel to the entire face, allow 30β60 seconds to absorb, (4) Non-comedogenic moisturizer, (5) Broad-spectrum SPF 30+ sunscreen (morning use). The gel should be applied once daily β typically in the evening to minimize photosensitivity interactions with BPO, though morning use is also acceptable. Do not apply additional active serums (AHAs, BHAs, vitamin C) in the same step. If you use any other prescription treatments, follow the specific protocol given by your dermatologist.
No β this formula has a very low comedogenic rating of 1 out of 5 and is considered non-comedogenic overall. The key potentially comedogenic ingredient, dimethicone, has a comedogenic rating of only 1 (very low). No pore-clogging oils, waxes, or heavy emollients are present in the formula. The aqueous gel base is lightweight and water-based. Furthermore, benzoyl peroxide itself has keratolytic (mild exfoliating) properties that help prevent pore clogging by promoting skin cell turnover. This gel is specifically formulated for acne-prone skin and is unlikely to cause pore congestion when used as directed.
Per FDA prescribing information, the pharmacy dispenses this product with a 10-week expiration date. Unused product should be discarded after this period β do not use beyond the dispensed expiry date. The limited shelf life is due to the chemical instability of benzoyl peroxide over time, which can degrade and become less effective. Prior to dispensing, the pharmacy stores it refrigerated (2Β°Cβ8Β°C). Once you have it home, store at room temperature (20Β°Cβ25Β°C / 68Β°β77Β°F), protect from freezing, keep the pump upright, and keep the cap closed tightly. A 50g pump used once daily (pea-sized amount per use) is typically sufficient for approximately 60β90 daily doses, so the 10-week supply aligns with standard treatment duration.
Verdict: Taro's Clindamycin Phosphate & Benzoyl Peroxide Gel 1.2%/3.75% is a clinically validated, FDA-approved prescription acne treatment that delivers the gold-standard combination of antibiotic + antibacterial therapy in a single, once-daily application. The optimized 3.75% BPO concentration offers meaningful tolerability advantages over higher-concentration alternatives while maintaining proven efficacy β with clinical studies demonstrating nearly 70% reduction in inflammatory lesions over 12 weeks. The fragrance-free, low-comedogenic, fungal-acne-safe formula is well-suited for oily and combination acne-prone skin. The main considerations are its prescription-only status, potential for initial dryness, the fabric-bleaching risk of BPO, and the need for careful storage. For patients with moderate-to-severe inflammatory acne who have a prescription from their dermatologist, this is among the most effective topical acne treatments available.
Product Overview
Quick product notes are a great way to check if a product is free from commonly avoided ingredients by skincare enthusiasts. These preferences come about for different reasons depending on the ingredient such as personal experiences, sensitivities, health preferences & etc.
Just because a product is not free from a common preference does not mean it's a bad product! You can make a personal decision whether or not you want to use a product that contains these ingredients or not - click the labels of the preference to read more about them.
Quick Product Notes
Ever used a product that promised a certain effect but provided no results? It might not have contained any notable ingredients that could have been responsible for that promised effect. It doesn't matter what the marketing or packaging Β«promisesΒ» it can do, if it doesn't contain anything that can help - then the likelihood of it helping is low.
We help you identify key notable ingredients that have been shown to help with effects such as acne-fighting, brightening, UV-protection, wound healing & anti-aging to help you achieve your skincare goals smarter. Please note that different notable ingredients have varying levels of research behind them, some are extremely well proven yet some have mixed research in their efficacy.
Just because a product doesn't contain any notable ingredients doesn't mean it's bad. And a product with notable ingredients (or even many) doesn't necessarily guarantee the efficacy of the product performing these effects either. There are other factors such as ingredient quality, concentration and formulation that will ultimately determine this.
Be smart and use this as just a starting point for you to make more informed and smarter choices and compare it with reviews to see if the product is right for you
Notable Effects & Ingredients
Why are some products great for some people and horrible for others? Well everyone has different skin types and different reactions to the same ingredients.
We've identified a range of ingredients that are commonly regarded as potentially good or bad for those with Dry, Oily/Acne-Prone or Sensitive skin.
A product that contains good or bad ingredients for your skin type doesn't always flat out make the entire product good or bad for your skin. There are other factors such as ingredient quality, concentration and formulation that will ultimately determine your skins reaction.
One of the best ways to use this section is to troubleshoot products you've had bad experiences with in the past. Check if it contains any of the marked ingredients to point out suspect ingredients to avoid in the future!
Ingredients Related to Skin Types
Ingredient Safety Breakdown refers to the percentage % of ingredients in different risk categories as classified by EWG (Environment Working Group) if they are available. There are almost endless cosmetic ingredients and they are one of the few organisations globally that have assigned ratings to a lot of the more commonly used ingredients which is why we reference them.
EWG is seen by many to be more on the alarmist side in their assignment of health ratings resulting in rating ingredients as riskier than they actually are. We recommend using this a reference point rather than a strict guide of ingredient safety and to always do further research if into ingredients that you may find suspect.
Ingredient Safety Breakdown
Product ingredient list
| EWG | CIR | Ingredient Name & Cosmetic Functions | Notes |
|---|---|---|---|
| 0 |
Clindamycin Phosphate
|
|
|
| 3 |
Dimethicone
Skin Conditioning, Emollient, Antifoaming Agent, Skin Protecting
|
|
|
| 1 |
Disodium Lauryl Sulfosuccinate
Skin Conditioning, Hydrotrope, Sufactant, Foam Boosting, Foaming
|
|
|
| 1 |
Disodium EDTA
Viscosity Controlling, Chelating Agent
|
|
|
| 2 |
Glycerin
Solvent, Perfuming, Fragrance, Humectant, Viscosity Decreasing Agent, Hair Conditioning, Skin Protecting, Denaturant, Skin Conditioning
|
Promotes Wound Healing
Hydrating
|

